{"result": "(\"entity\"<|>ROSA BURGOS PELÁEZ<|>PERSON<|>Rosa Burgos Peláez is a doctor involved in the study of lipid metabolism disorders, specifically adrenoleukodystrophy and controlled diets in fatty acids.)\n##\n(\"entity\"<|>MIREIA GUERRERO GUAL<|>PERSON<|>Mireia Guerrero Gual is a doctor who collaborates on research related to lipid metabolism disorders.)\n##\n(\"entity\"<|>GUILLERMO CÁRDENAS LAGRANJA<|>PERSON<|>Guillermo Cárdenas Lagranja is a doctor contributing to the study of lipid metabolism disorders.)\n##\n(\"entity\"<|>HEGOI SEGUROLA GURRUTXAGA<|>PERSON<|>Hegoi Segurola Gurrutxaga is a doctor involved in research on lipid metabolism disorders.)\n##\n(\"entity\"<|>M.ª NURIA VIRGILI CASAS<|>PERSON<|>M.ª Nuria Virgili Casas is a doctor studying chylothorax and chylous ascites with modified triglyceride diets.)\n##\n(\"entity\"<|>RAFAEL LÓPEZ URDIALES<|>PERSON<|>Rafael López Urdiales is a doctor involved in the research of chylothorax and chylous ascites.)\n##\n(\"entity\"<|>EVA MARÍA GARCÍA RAIMUNDO<|>PERSON<|>Eva María García Raimundo is a doctor contributing to the study of chylothorax and chylous ascites.)\n##\n(\"entity\"<|>MÓNICA MONTSERRAT GIL DE BERNABÉ<|>PERSON<|>Mónica Montserrat Gil de Bernabé is a doctor involved in research on chylothorax and chylous ascites.)\n##\n(\"entity\"<|>PERE LEYES I GARCÍA<|>PERSON<|>Pere Leyes i García is a doctor studying epilepsy and ketogenic diets.)\n##\n(\"entity\"<|>JOAN TRABAL VÍLCHEZ<|>PERSON<|>Joan Trabal Vílchez is a doctor involved in the research of epilepsy and ketogenic diets.)\n##\n(\"entity\"<|>HOSPITAL CLÍNICO UNIVERSITARIO SAN CARLOS<|>ORGANIZATION<|>Hospital Clínico Universitario San Carlos is a medical institution in Madrid focusing on clinical nutrition and endocrinology.)\n##\n(\"entity\"<|>CENTRO DE SALUD LUCERO<|>ORGANIZATION<|>Centro de Salud Lucero is a primary healthcare center located in Madrid.)\n##\n(\"entity\"<|>MADRID<|>GEO<|>Madrid is the capital city of Spain, where significant medical research and healthcare services are provided.)\n##\n(\"entity\"<|>DIETOTERAPIA, NUTRICIÓN CLÍNICA Y METABOLISMO<|>EVENT<|>Dietoterapia, nutrición clínica y metabolismo is a publication discussing dietary therapy and clinical nutrition, focusing on lipid metabolism.)\n##\n(\"relationship\"<|>ROSA BURGOS PELÁEZ<|>HOSPITAL CLÍNICO UNIVERSITARIO SAN CARLOS<|>Rosa Burgos Peláez works at Hospital Clínico Universitario San Carlos, contributing to research on lipid metabolism disorders.<|>8)\n##\n(\"relationship\"<|>MIREIA GUERRERO GUAL<|>HOSPITAL CLÍNICO UNIVERSITARIO SAN CARLOS<|>Mireia Guerrero Gual is affiliated with Hospital Clínico Universitario San Carlos, focusing on lipid metabolism disorders.<|>8)\n##\n(\"relationship\"<|>GUILLERMO CÁRDENAS LAGRANJA<|>HOSPITAL CLÍNICO UNIVERSITARIO SAN CARLOS<|>Guillermo Cárdenas Lagranja is a researcher at Hospital Clínico Universitario San Carlos, studying lipid metabolism disorders.<|>8)\n##\n(\"relationship\"<|>HEGOI SEGUROLA GURRUTXAGA<|>HOSPITAL CLÍNICO UNIVERSITARIO SAN CARLOS<|>Hegoi Segurola Gurrutxaga is involved in research at Hospital Clínico Universitario San Carlos on lipid metabolism disorders.<|>8)\n##\n(\"relationship\"<|>M.ª NURIA VIRGILI CASAS<|>HOSPITAL CLÍNICO UNIVERSITARIO SAN CARLOS<|>M.ª Nuria Virgili Casas conducts research at Hospital Clínico Universitario San Carlos on chylothorax and chylous ascites.<|>8)\n##\n(\"relationship\"<|>RAFAEL LÓPEZ URDIALES<|>HOSPITAL CLÍNICO UNIVERSITARIO SAN CARLOS<|>Rafael López Urdiales is a researcher at Hospital Clínico Universitario San Carlos studying chylothorax and chylous ascites.<|>8)\n##\n(\"relationship\"<|>EVA MARÍA GARCÍA RAIMUNDO<|>HOSPITAL CLÍNICO UNIVERSITARIO SAN CARLOS<|>Eva María García Raimundo is involved in research at Hospital Clínico Universitario San Carlos on chylothorax and chylous ascites.<|>8)\n##\n(\"relationship\"<|>MÓNICA MONTSERRAT GIL DE BERNABÉ<|>HOSPITAL CLÍNICO UNIVERSITARIO SAN CARLOS<|>Mónica Montserrat Gil de Bernabé conducts research at Hospital Clínico Universitario San Carlos on chylothorax and chylous ascites.<|>8)\n##\n(\"relationship\"<|>PERE LEYES I GARCÍA<|>HOSPITAL CLÍNICO UNIVERSITARIO SAN CARLOS<|>Pere Leyes i García is a researcher at Hospital Clínico Universitario San Carlos studying epilepsy and ketogenic diets.<|>8)\n##\n(\"relationship\"<|>JOAN TRABAL VÍLCHEZ<|>HOSPITAL CLÍNICO UNIVERSITARIO SAN CARLOS<|>Joan Trabal Vílchez is involved in research at Hospital Clínico Universitario San Carlos on epilepsy and ketogenic diets.<|>8)\n##\n(\"relationship\"<|>MIGUEL A. RUBIO<|>HOSPITAL CLÍNICO UNIVERSITARIO SAN CARLOS<|>Miguel A. Rubio is affiliated with Hospital Clínico Universitario San Carlos, focusing on the influence of diet on hyperlipemia and cardiovascular risk.<|>8)\n##\n(\"relationship\"<|>CARMEN MORENO<|>CENTRO DE SALUD LUCERO<|>Carmen Moreno works at Centro de Salud Lucero, focusing on primary healthcare in Madrid.<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: MA 20.     Trastornos congénitos del metabolismo de los lípidos:\n             Adrenoleucodistrofia. Dieta controlada en ácidos grasos.\n             Dres. Rosa Burgos Peláez, Mireia Guerrero Gual, Guillermo Cárdenas Lagranja\n             y Hegoi Segurola Gurrutxaga\nTEMA 21.     Quilotórax y ascitis quilosa. Dietas modificadas en triglicéridos\n             de cadena larga y cadena media.\n             Dres. M.ª Nuria Virgili Casas, Rafael López Urdiales, Eva María García Raimundo\n             y Mónica Montserrat Gil de Bernabé\nTEMA 22.     Epilepsia. Dietas cetogénicas.\n             Dres. Pere Leyes i García y Joan Trabal Vílchez\n---\nNO_CONTENT_HERE\n---\nTema 19.\nInfluencia de la dieta en el control de la hiperlipemia\ny el riesgo cardiovascular\nMiguel A. Rubio\nSección de Nutrición Clínica y Dietética, Servicio de Endocrinología y Nutrición, Hospital Clínico\nUniversitario San Carlos. Madrid\nCarmen Moreno\nAtención Primaria. Centro de Salud Lucero (Madrid)\n\n\n\nDietoterapia, nutrición clínica y metabolismo. Tercera edición. Copyright 2017 de los autores, SEEN y Grupo Aula Médica.\nTodos los derechos reservados. Páginas 325-343.\n\n\n\n   1.  Introducción\n   2.  Influencia de los ácidos grasos sobre el riesgo cardiovascular\n   3.  Efectos de los esteroles sobre el riesgo cardiovascular\n   4.  Recomendaciones para reducir el impacto de una dieta aterogénica\n   5.  Recomendaciones nutricionales que pueden tener un impacto adicional sobre el riesgo cardiovascular\n   6.  Nutrientes y salud cardiometabólica\n   7.  Guías de recomendaciones nutricionales\n   8.  Bibliografía\n\n\n\n1.   Introducción                                                          medad cardiovascular (ECV)1 . La ingestión de diferen-\n                                                                           tes  cantidades      de  ácidos    grasos    y  colesterol  sigue\n   Los hábitos alimentarios de los países occidentales                     siendo la referencia de las pautas nutricionales indica-\nestán íntimamente ligados al desarrollo de enfermeda-                      das en la prevención y tratamiento de las dislipemias.\ndes crónicas prevalentes como son las enfermedades                         Pero conviene resaltar que disponemos de otros ele-\ncardiovasculares o ciertos tipos de cáncer. En el caso                     mentos de la dieta (vitaminas, minerales, fitoquímicos,\nconcreto de las hiperlipemias, la alimentación es res-                     etc.) que también son determinantes en esta relación\nponsable del 90-95% de los niveles de lípidos plasmá-                      dieta y riesgo cardiovascular, de tal manera que, hoy\nticos, ocupando la genética un lugar menos relevante                       en día, existen mecanismos dependientes de ciertos\ncomo responsable directo de la aparición de una hiper-                     nutrientes de la dieta que van más allá de la simple\nlipemia y su asociación con la arteriosclerosis.                           teoría lípidica de la arteriosclerosis (tabla 1). En esta\n   Aunque existen factores genéticos que predisponen                       revisión vamos a resaltar aquellos aspectos más rele-\na la aparición precoz de una arteriosclerosis en cual-                     vantes que debemos tener presentes a la hora de pre-\nquiera de sus manifestaciones clínicas (enfermedad                         venir el riesgo cardiovascular o la aproximación dieto-\ncoronaria, accidente cerebrovascular o enfermedad ar-                      terápica ante una dislipemia.\nterial periférica), pueden estar presentes otra serie de\nfactores de riesgo cardiovasculares, ampliamente reco-                     2.   Influencia de los ácidos grasos sobre\nnocidos, que pueden acelerar el desarrollo de las pla-                          el riesgo cardiovascular\ncas de ateroma y, por consiguiente, expresarse con\nmayor precocidad. Nos referimos a la presencia de dia-                        Diversos estudios epidemiológicos desarrollados a\nbetes, hipertensión arterial, obesidad, tabaquismo, se-                    partir de la década de los sesenta, entre los que figura\ndentarismo, etc., que contribuyen de manera combi-                         como más representativo el estudio de siete países2, de-\nnada a una rápida progresión de la arteriosclerosis.                       jaron constancia de la estrecha relación entre el consu-\n   El tipo de dieta de cada población es el principal de-                  mo de grasa y de ciertos tipos de ácidos grasos con la\nterminante de las manifestaciones clínicas de la enfer-                    ECV. Se implicó por vez primera a las grasas saturadas y\n\n\n\n                                                                      325\n---\n 326     BLOQUE: LÍPIDOS\n\n\n\n                  Tabla 1.   Nut\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}